| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 25 |
| 1 | DEXAMETHASONE | 20 |
| 2 | DEXAMETHASONE 1.5 MG | 20 |
| 3 | METHOTREXATE SODIUM | 19 |
| 4 | THIOTEPA | 19 |
| 5 | CYTARABINE | 17 |
| 6 | FLUDARABINE PHOSPHATE | 17 |
| 7 | PONATINIB HYDROCHLORIDE | 16 |
| 8 | VINCRISTINE SULFATE | 16 |
| 9 | CYCLOPHOSPHAMIDE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PONATINIB HYDROCHLORIDE | 16 | 0.0043 |
| 1 | THIOTEPA | 19 | 0.0041 |
| 2 | VINCRISTINE SULFATE | 16 | 0.0010 |
| 3 | BUSULFAN | 9 | 0.0008 |
| 4 | FLUDARABINE PHOSPHATE | 17 | 0.0008 |
| 5 | MERCAPTOPURINE | 7 | 0.0006 |
| 6 | CYTARABINE | 17 | 0.0005 |
| 7 | RITUXIMAB | 25 | 0.0003 |
| 8 | BRENTUXIMAB VEDOTIN | 1 | 0.0002 |
| 9 | DOXORUBICIN HYDROCHLORIDE | 5 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0002 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 25 | 0.0002 |
| 2 | Immunoglobulin G [EPC] | 1 | 0.0002 |
| 3 | Alkylating Drug [EPC] | 21 | 0.0001 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 17 | 0.0001 |
| 5 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 4 | 0.0001 |
| 7 | Corticosteroid [EPC] | 26 | 0.0000 |
| 8 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |